Cerebral microbleeds are tiny deposits of blood-breakdown products in brain tissue, visible on certain MRI sequences as small dark spots typically a few millimeters across. They are remarkably common, especially as people age, and most of the time they produce no symptoms at all. But their presence tells your doctor something important about the health of the small blood vessels in your brain, and depending on where and how many show up, they can influence decisions about stroke treatment, blood-thinning medication, and long-term cognitive risk.
How MRI Picks Them Up
Microbleeds are not active bleeding. They are old, healed leaks from tiny blood vessels, leaving behind hemosiderin, an iron-rich residue from broken-down red blood cells. Because iron is strongly magnetic, these deposits create a distinctive signal disruption on specialized MRI sequences. Gradient-echo and susceptibility-weighted imaging (SWI) are the sequences most sensitive to this effect, and they make microbleeds appear as small, round, dark dots against the surrounding brain tissue.1PubMed Central. Cerebral microbleeds: overview and implications in cognitive impairment
Standard MRI sequences used for routine brain scans can easily miss microbleeds entirely. Stronger magnets also help: a comparison of 1.5-Tesla and 3-Tesla MRI scanners in patients with traumatic brain injury found that the higher-strength scanner detected roughly twice as many microbleeds.2PubMed. Comparative magnetic resonance imaging at 1.5 and 3 Tesla for the evaluation of traumatic microbleeds So if your MRI report mentions microbleeds, the number listed depends partly on the technology used. A scan at a different facility with a stronger magnet might reveal more.
Even with good imaging, MRI does not catch everything. A study that compared pre-mortem MRI findings with what pathologists actually found under the microscope reported that MRI detected only about half of the microbleeds present in brain tissue, while about four out of every thirty-one lesions flagged on MRI turned out to be false positives.3PubMed Central. Radiologic-Histopathologic Correlation of Cerebral Microbleeds Using Pre-Mortem and Post-Mortem MRI Small calcifications, blood vessels seen end-on, and certain mineral deposits can all mimic microbleeds on imaging. Radiologists are trained to look for these mimics, but occasional misidentification is part of the landscape.
How Common Are They
If you have been told you have microbleeds, you are far from alone. Data from the Rotterdam Scan Study found that about 15% of all participants had at least one microbleed on MRI. Prevalence climbed steeply with age, from roughly 6.5% in people aged 45 to 50 up to about 36% in those 80 and older.4Stroke. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study In other words, by the time you reach your eighties, there is better than a one-in-three chance your brain has at least one of these tiny old bleeds. Most people who have them never know it unless they happen to get a brain MRI for some other reason.
What Causes Them
The two overwhelmingly dominant causes of cerebral microbleeds are high blood pressure and a condition called cerebral amyloid angiopathy, or CAA. Less common causes include traumatic brain injury, certain inherited blood-vessel diseases, brain radiation therapy, vasculitis, and blood-vessel malformations.5PubMed. MRI of cerebral microhemorrhages
Where the microbleeds sit in the brain often points toward the underlying cause. Hypertension tends to damage the small arteries deep inside the brain, in areas like the basal ganglia, thalamus, and brainstem. Microbleeds from high blood pressure therefore cluster in these deep and infratentorial (below the tentorium, a membrane separating the cerebrum from the cerebellum) locations.6PubMed Central. Hypertension-Related Cerebral Microbleeds Cerebral amyloid angiopathy, on the other hand, involves the buildup of amyloid protein in the walls of blood vessels closer to the brain’s surface. Microbleeds from CAA tend to appear in the outer cortical regions, particularly the frontal and parietal lobes.
Research has refined this distinction even further. A 2024 study found that when lobar microbleeds sat right at the cortical surface rather than slightly deeper in the subcortical white matter, they were far more strongly linked to CAA. Strictly intracortical microbleeds were strongly associated with amyloid angiopathy, while subcortical lobar microbleeds pointed more toward hypertensive arterial disease.7PubMed Central. Differences in lobar microbleed topography in cerebral amyloid angiopathy and hypertensive arteriopathy This is more than an academic exercise: the distinction affects treatment decisions and the kind of monitoring your doctor might recommend.
Microbleeds and Future Stroke Risk
This is probably the question that matters most if you have just been told about microbleeds on your scan. The short answer is that microbleeds do raise the risk of a future stroke, and the relationship gets stronger as the number of microbleeds increases. But the story is more nuanced than a simple alarm bell.
A large pooled analysis of individual patient data from people who had already had an ischemic stroke or transient ischemic attack found that having microbleeds increased the risk of a future brain hemorrhage, with the hazard climbing substantially as the count went up. For people with five or more microbleeds, the risk of intracranial hemorrhage was roughly four and a half times higher than for people without them, and for those with twenty or more, it was about eight and a half times higher. The risk of another ischemic stroke also rose, but much less steeply.8PubMed Central. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies
Here is a finding that surprises many people: even in patients with a high microbleed burden, ischemic strokes still outnumbered hemorrhagic strokes. Among those with ten or more microbleeds, the rate of ischemic stroke was roughly 64 per 1,000 patient-years compared to 27 intracranial hemorrhages per 1,000 patient-years.8PubMed Central. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies That matters because it means even patients with many microbleeds still face more danger from blood clots blocking arteries than from bleeding, a fact that weighs into treatment decisions about anticoagulant drugs.
In healthy older adults without a history of stroke, a population-based study found an even more dramatic disparity: microbleeds in the deep brain were associated with a roughly fifty-fold increase in the hazard for a deep brain hemorrhage, while the increase in ischemic stroke risk was about fourfold.9Stroke. Microbleeds Are Associated With Subsequent Hemorrhagic and Ischemic Stroke in Healthy Elderly Individuals Those hemorrhagic numbers sound alarming, but deep brain hemorrhage is rare to begin with, so a large relative increase in a rare event still translates to a small absolute risk for any individual.
A separate meta-analysis looking specifically at people who had already suffered an ischemic stroke or TIA found that having microbleeds roughly doubled the odds of any recurrent stroke and increased the odds of a hemorrhagic stroke by more than eightfold.10PubMed. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts
What This Means for Blood Thinners and Clot-Busting Drugs
The intersection of microbleeds and anticoagulant therapy is one of the trickiest dilemmas in stroke medicine. Many people with microbleeds also have conditions like atrial fibrillation that put them at high risk for clot-based strokes, making blood thinners essential. But blood thinners, by definition, raise the risk of bleeding. When someone already has evidence of fragile brain blood vessels, doctors have to weigh those competing risks carefully.
A meta-analysis of stroke patients with atrial fibrillation found that having five or more microbleeds was linked to a significantly higher annual rate of brain hemorrhage while on anticoagulation therapy, rising from about 0.3% per year in people without microbleeds to roughly 2.5% per year in those with five or more.11PubMed. Brain microbleeds, anticoagulation, and hemorrhage risk: Meta-analysis in stroke patients with AF That is a meaningful jump, but it still means the large majority of people with five or more microbleeds on anticoagulants do not bleed in any given year. Meanwhile, stopping blood thinners exposes them to clot-based strokes. One study of patients with both microbleeds and atrial fibrillation-related stroke found no significant increase in hemorrhagic events or death among those continuing antithrombotic therapy compared to those without microbleeds.12PubMed Central. The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
For acute clot-busting treatment during an ischemic stroke, the picture is similar. Evidence from the ENCHANTED trial found that having microbleeds was not associated with a significant increase in serious bleeding complications after intravenous thrombolysis.13PubMed. Intravenous thrombolysis in patients with acute ischemic stroke and cerebral microbleeds: Results from the ENCHANTED trial A separate retrospective study found the same general pattern: the presence of microbleeds alone did not predict serious hemorrhage after acute stroke treatment. The exception was patients with a very high burden of more than ten microbleeds, where the risk of symptomatic bleeding jumped dramatically.14PubMed Central. Cerebral microbleeds shouldn’t dictate treatment of acute stroke: a retrospective cohort study evaluating risk of intracerebral hemorrhage The practical takeaway is that a few microbleeds should not, by themselves, prevent someone from receiving lifesaving stroke treatment, though a very high count raises a flag that requires careful judgment.
Microbleeds and Cognitive Decline
Beyond stroke, microbleeds carry implications for thinking and memory. A systematic review and meta-analysis found that people with microbleeds had roughly double the risk of progressing to dementia over time.15PubMed Central. Do cerebral microbleeds increase the risk of dementia? A systematic review and meta-analysis This held true both in high-risk populations and in the general community.
But as with stroke risk, the number of microbleeds matters more than their mere existence. A population-based study from the Rotterdam Scan Study found that having any single microbleed was not associated with cognitive decline over about six years of follow-up. The link emerged only when people had more than four. At that point, lower scores on tests of information processing speed, word fluency, and memory became apparent. Lobar microbleeds were most strongly tied to declines in processing speed, while deep or infratentorial microbleeds were most linked to drops in motor speed.16JAMA Neurology. Association of Cerebral Microbleeds With Cognitive Decline and Dementia The same study found that the presence of microbleeds in any location roughly doubled the risk of developing dementia during follow-up.
Another meta-analysis added the finding that having two or more microbleeds was particularly associated with a higher risk of dementia, and that deep or mixed-location microbleeds were specifically linked to vascular dementia.17Brain Disorders. Association of cerebral microbleeds with risks of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies This makes sense given that deep microbleeds tend to reflect the kind of small-vessel damage that starves brain tissue of blood flow over time.
Microbleeds After a Head Injury
Not all microbleeds on an MRI come from vascular disease. After a traumatic brain injury, microbleeds can appear throughout the brain, typically at the junction between gray and white matter where shearing forces are strongest. Their presence is one way doctors gauge the severity of diffuse axonal injury, although the relationship is not as straightforward as it might seem.
Research from a neuropathology study found that only about two-thirds of traumatic microbleeds showed evidence of axonal injury on histological examination. When the analysis was refined using more conservative thresholds, roughly 45% of microbleeds had no significant axonal damage associated with them at all.18PubMed Central. Traumatic Microhemorrhages Are Not Synonymous With Axonal Injury In other words, a traumatic microbleed on MRI tells you that a blood vessel broke, but it does not automatically mean the nerve fibers nearby were torn. Some microbleeds mark mechanical vascular rupture without extensive tissue disruption. This distinction matters clinically because the degree of axonal injury, not the bleeding itself, is what tends to drive long-term outcomes after a concussion or more severe brain trauma.
Imaging studies have confirmed this dissociation from the opposite direction. Susceptibility-weighted imaging (which picks up microbleeds) and diffusion tensor imaging (which detects disrupted white matter tracts) identified largely distinct groups of patients after TBI, with some patients showing microbleeds but no diffusion abnormalities, and vice versa.19Brain. Detecting axonal injury in individual patients after traumatic brain injury
The Emotional Side
Most discussions of microbleeds focus on stroke and dementia risk, but there is emerging evidence that they contribute to mood changes as well. A study of survivors of spontaneous intracerebral hemorrhage found that patients with depression and anxiety symptoms had significantly more deep microbleeds than those without. After adjusting for other factors, deep microbleeds were independently associated with these affective symptoms, and cognitive impairment appeared to partially explain the link.20PubMed Central. Cerebral Microbleeds and Long-Term Affective Symptoms in Survivors of Spontaneous Intracerebral Hemorrhage This is a single study in a specific population, so it would be premature to draw broad conclusions, but it aligns with what we know about how damage to deep brain structures can disrupt emotional regulation circuits.
Sleep Apnea as a Risk Factor
A 2025 study added an unexpected contributor to the list of microbleed risk factors: obstructive sleep apnea. Middle-aged and older adults with moderate-to-severe sleep apnea had roughly twice the risk of developing new microbleeds over eight years compared to those without sleep apnea. Milder sleep apnea did not carry the same risk, and the association held regardless of whether the person carried the APOE-ε4 gene variant linked to Alzheimer’s disease.21JAMA Network Open. Obstructive Sleep Apnea and Cerebral Microbleeds in Middle-Aged and Older Adults The likely mechanism involves the repeated drops in blood oxygen and surges in blood pressure that occur with each apnea episode, which over years may weaken small blood vessels. If you have moderate-to-severe sleep apnea and have been putting off treatment, this is one more reason to take it seriously.
Blood Pressure Control and Microbleed Progression
Since hypertension is one of the two main drivers of microbleeds, it stands to reason that controlling blood pressure could slow their progression. Research supports this. A study tracking patients with essential hypertension over two years found that high ambulatory blood-pressure levels were significant predictors of new microbleeds appearing.22American Journal of Hypertension. Progression of Brain Microbleeds in Essential Hypertensive Patients: A 2-Year Follow-up Study Another study showed that blood-pressure variability, the swings between high and low readings rather than the average level alone, independently predicted the growth of deep and infratentorial microbleeds.23PubMed. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions Both of these are potentially modifiable with medication and lifestyle changes, which makes managing hypertension one of the few concrete actions you can take if microbleeds are discovered on your scan.
Microbleeds and New Alzheimer’s Drugs
A newer and rapidly evolving area involves cerebral microbleeds and the latest generation of Alzheimer’s disease treatments. Drugs like lecanemab and aducanumab are monoclonal antibodies designed to clear amyloid plaques from the brain. They have shown the ability to slow clinical decline, but their use is complicated by a side effect called Amyloid-Related Imaging Abnormalities, or ARIA, which can manifest as brain swelling or new microhemorrhages.24Journal of Internal Medicine Research & Reports. Adverse Effects ARIA (ARIA-E and ARIA-H) in Aducanumab and Lecanemab According to APOE Genotype: Systematic Review of the Literature
The suspected mechanism involves the rapid clearance of amyloid from blood-vessel walls. When the antibodies pull amyloid out of vessels already weakened by years of amyloid buildup, those vessels can become temporarily more permeable, leading to fluid leakage or small bleeds.25PubMed Central. Two cases of Amyloid-Related Imaging Abnormalities (ARIA) following lecanemab treatment for alzheimer’s disease and a literature review Patients who already have multiple microbleeds before starting treatment, particularly those with underlying cerebral amyloid angiopathy, are at higher risk for ARIA. This is why baseline MRI screening for microbleeds is now a standard step before initiating these therapies. If you have a significant microbleed burden, your neurologist may recommend against these drugs or adopt more intensive monitoring.
What Microbleeds Actually Look Like Under the Microscope
There is a common assumption that every dark dot on an MRI represents the same thing. Under the microscope, the reality is more varied. A histopathological study of cortical microbleeds in patients with cerebral amyloid angiopathy found three distinct categories: some corresponded to fresh red blood cells suggesting recent hemorrhage, others showed damaged vessel walls without substantial tissue injury, and the majority turned out to be clusters of iron-laden immune cells (siderophages) from old, resolved bleeds combined with signs of chronic low-level tissue damage.26Neurology. Heterogeneous histopathology of cortical microbleeds in cerebral amyloid angiopathy
Post-mortem 7-Tesla MRI combined with tissue analysis of patients who died from intracerebral hemorrhage identified over 200 microbleeds across 15 patients, confirming that they are often abundant even in tissue that looked unremarkable on clinical-strength scanners.27PubMed Central. Histopathology of Cerebral Microinfarcts and Microbleeds in Spontaneous Intracerebral Hemorrhage The takeaway is that microbleeds are not all the same event captured at the same moment. Some are active, some are scarred-over remnants of past events, and some reflect ongoing vessel-wall damage without frank bleeding. This heterogeneity is one reason why a simple count on MRI, while useful as a rough risk indicator, does not tell the whole story about what is happening in any individual brain.